Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 6, 2002, Pages 581-586

  Schoen, Robert E ^a,b   Schragin, Jeff ^a   Weissfeld, Joel L ^a   Thaete, F Leland ^a,c   Evans, Rhobert W ^a   Rosen, Clifford J ^d   Kuller, Lewis H ^a  

^a Division of Gastroenterology   (United States)

^b Departments of Psychiatry and Medicine   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; AGED; BODY COMPOSITION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEX FACTORS; VISCERA;

EID: 0036280892     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Role of the insulin-like growth factor family in cancer development and progression
2. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3
3. Serum C-peptide, insulin-like growth factor (IGF)-1. IGF-binding proteins, and colorectal cancer risk in women
4. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women
5. Insulin-like growth factor-binding protein-1 and prostate cancer
6. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
7. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study
8. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer
9. Joint effect of insulin-like growth factors and mulagen sensitivity in lung cancer risk
10. Insulin-like growth factors and their binding proteins: Biological actions
11. Serum levels of insulin-like growth factor-1 are related to age and not to body composition in healthy women and men
12. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men
13. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in healthy premenopausal women
14. Relationships between IGP-1 and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients
15. Colon cancer: A review of the epidemiology
16. Body mass index and fatal colon cancer in a large prospective study
17. Body weight and mortality among women
18. Insulin and colon cancer
19. Increased blood glucose and insulin, body size, and incident colorectal cancer
20. Insulin like growth factors and binding proteins in colon cancer
21. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet
22. Insulin promotion of colon tumors in rats
23. Relation of body fat distribution to metabolic complications of obesity
24. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
25. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution
26. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women
27. Prostate Lung Colorectal and Ovarian Cancer screening trial project learn. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer screening trial
28. A comparative analysis of methods to measure IGF-1 in human serum
29. Adipose tissue volume determinations in women by computed loography: Lechnical considerations
30. Assessment of abdominal fat content by computed oography
31. Dipose tissue determinations in cadavers - A comparison between cross-sectional planimetry and computed omography
32. Sagittal diameter in comparison with single slice CT as a predictor of lotal visceral adipose tissue volume
33. Reproducibility of computed tomography measurement of visceral adipose tissue area
34. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
35. Nutritional regulation of the insulin-like growth factors
36. Serum insulin-like growth factor 1 in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
37. The relationship between insulin-like growth factor-I, adiposity, and aging
38. Population-based reference values for IGF-I and IGF-binding protein-I: Relations with metabolic and anthropometric variables
39. Low concentrations of insulin-like growth factor-1 in abdominal obesity
40. Relationship between plasma insulin-like growth factor I (IGF-1) levels and body mass index (BMI) in adults
41. Serum free IGIF-I, total IGF-I, IGFBP-I and IGFBP-3 levels in an elderly population: Relation to age and sex steroid levels
42. Growth hormone (GH) regulation of cytochrome P-45011C12, insulin-like growth factor-I (IGF-I), and GH receptor messenger RNA expression in primary rat hepatocytes: A hormonal interplay with insulin, IGF-I, and thyroid hormone
43. Insulin-like growth factor binding protein-I: Recent findings and new directions
44. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
45. Prostate Lung Colorectal and Ovarian Cancer screening trial project team. Recruitment strategies in the Prostate. Lung. Colorectal and Ovarian (PLCO) Cancer screening trial: The first six years